These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
143 related items for PubMed ID: 2126281
1. Neopterin and beta-2 microglobulin levels in asymptomatic HIV infection: the predictive value of combining markers. Harrison NA, Skidmore SJ. J Med Virol; 1990 Oct; 32(2):128-33. PubMed ID: 2126281 [Abstract] [Full Text] [Related]
2. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. Fahey JL, Taylor JM, Detels R, Hofmann B, Melmed R, Nishanian P, Giorgi JV. N Engl J Med; 1990 Jan 18; 322(3):166-72. PubMed ID: 1967191 [Abstract] [Full Text] [Related]
3. Surrogate markers for AIDS treatment. Jacobson M. Nurs Times; 1990 Jan 18; 87(22):49. PubMed ID: 1675013 [No Abstract] [Full Text] [Related]
4. Immune activation markers and AIDS prognosis. Osmond DH, Shiboski S, Bacchetti P, Winger EE, Moss AR. AIDS; 1991 May 18; 5(5):505-11. PubMed ID: 1677808 [Abstract] [Full Text] [Related]
5. Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine. Jacobson MA, Bacchetti P, Kolokathis A, Chaisson RE, Szabo S, Polsky B, Valainis GT, Mildvan D, Abrams D, Wilber J. BMJ; 1991 Jan 12; 302(6768):73-8. PubMed ID: 1671651 [Abstract] [Full Text] [Related]
6. Immunologic markers of progression to acquired immunodeficiency syndrome are time-dependent and illness-specific. Krämer A, Biggar RJ, Hampl H, Friedman RM, Fuchs D, Wachter H, Goedert JJ. Am J Epidemiol; 1992 Jul 01; 136(1):71-80. PubMed ID: 1384311 [Abstract] [Full Text] [Related]
7. [ Biological criteria for prediction of the clinical course leading to AIDS]. Salmon D, Couroucé AM, Doinel C, Fine JM, Kaplan C, Lambin P, Lefrère JJ, Rouger P, Salmon C. Rev Fr Transfus Hemobiol; 1990 Dec 01; 33(6):407-14. PubMed ID: 1981002 [No Abstract] [Full Text] [Related]
8. Relationship and prognostic value of endogenous interferon-alpha, beta 2-microglobulin, and neopterin serum levels in patients with Kaposi sarcoma and AIDS. Krown SE, Niedzwiecki D, Bhalla RB, Flomenberg N, Bundow D, Chapman D. J Acquir Immune Defic Syndr (1988); 1991 Dec 01; 4(9):871-80. PubMed ID: 1895208 [Abstract] [Full Text] [Related]
9. Serum levels of soluble CD8, neopterin, beta 2-microglobulin and p24 antigen as indicators of disease progression in children with AIDS on zidovudine therapy. Siller L, Martin NL, Kostuchenko P, Beckett L, Rautonen J, Cheng SC, Wara DW. AIDS; 1993 Mar 01; 7(3):369-73. PubMed ID: 8097095 [Abstract] [Full Text] [Related]
10. Effect of azidothymidine (AZT) on HIV P24 antigen, beta 2-microglobulin, neopterin, soluble CD8, soluble interleukin-2 receptor and tumor necrosis factor alpha levels in patients with AIDS-related complex or AIDS. Reddy MM, McKinley G, Englard A, Grieco MH. Int J Immunopharmacol; 1990 Mar 01; 12(7):737-41. PubMed ID: 2127261 [Abstract] [Full Text] [Related]
11. [HIV-1 antigenemia and T-cell activation in HIV-1 infected patients]. Harrer T, Wolf B, Kersten W, Schwarz W, Bergner D, Kalden JR. Klin Wochenschr; 1990 Sep 03; 68(17):864-8. PubMed ID: 2214610 [Abstract] [Full Text] [Related]
12. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. Dis Markers; 1990 Sep 03; 8(3):164-5. PubMed ID: 2125538 [No Abstract] [Full Text] [Related]
13. 2',5'-oligoadenylate synthetase, neopterin and beta 2-microglobulin in asymptomatic HIV-infected individuals. Witt PL, Spear GT, Lindstrom MJ, Kessler HA, Borden EC, Phair J, Landay AL. AIDS; 1991 Mar 03; 5(3):289-93. PubMed ID: 2059368 [Abstract] [Full Text] [Related]
14. Clinical and laboratory predictors of survival in Gambian patients with symptomatic HIV-1 or HIV-2 infection. Whittle H, Egboga A, Todd J, Corrah T, Wilkins A, Demba E, Morgan G, Rolfe M, Berry N, Tedder R. AIDS; 1992 Jul 03; 6(7):685-9. PubMed ID: 1354448 [Abstract] [Full Text] [Related]
15. Virologic and serologic markers of rapid progression to AIDS after HIV-1 seroconversion. Farzadegan H, Henrard DR, Kleeberger CA, Schrager L, Kirby AJ, Saah AJ, Rinaldo CR, O'Gorman M, Detels R, Taylor E, Phair JP, Margolick JB. J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Dec 15; 13(5):448-55. PubMed ID: 8970472 [Abstract] [Full Text] [Related]
16. Behaviour of different clinical, immunological and serological parameters observed in a group of HIV positive patients during a 12 month treatment period with zidovudine. Crocchiolo PR, Lizioli A, Arcidiacono I, Cantaluppi P, Filippi C, Sobatti D, Bedarida G, D'Agostino F, Cambie G, Nardella ML. Boll Ist Sieroter Milan; 1990 Jun 15; 69(2):423-30. PubMed ID: 1983798 [Abstract] [Full Text] [Related]
17. Prognostic value of serum beta 2-microglobulin in HIV infection. Krämer A, Goedert JJ, Wachter H, Fuchs D. Lancet; 1992 Aug 08; 340(8815):371. PubMed ID: 1379663 [No Abstract] [Full Text] [Related]
18. Serum beta 2-microglobulin levels in asymptomatic HIV-1-infected subjects during long-term zidovudine treatment. Mulder JW, Krijnen P, Coutinho RA, Bakker M, Goudsmit J, Lange JM. Genitourin Med; 1991 Jun 08; 67(3):188-93. PubMed ID: 1906425 [Abstract] [Full Text] [Related]
19. Evaluation on HIV serology and immune-stimulation on patients in Tanzania. Hengster P, Schmutzhard E, Fuchs D, Hofbauer J, Wachter H, Dierich MP. Int J STD AIDS; 1991 Jun 08; 2(3):180-4. PubMed ID: 1907499 [Abstract] [Full Text] [Related]
20. [Serum neopterin and beta2-microglobulin concentration as "prognostic markers" of AIDS]. Halota W, Jaruga B, Pawłowska M. Pol Merkur Lekarski; 2002 Aug 08; 13(74):126-8. PubMed ID: 12420343 [Abstract] [Full Text] [Related] Page: [Next] [New Search]